In COVID-19 patients, those who had AKI had significantly higher IL-6 levels compared with those who did not have AKI (20.4 vs. 5.53 pg/mL), whereas we had the same trend for SAA (300.0 vs. 77.40 μg/L). The gene discussed is IL6; the disease is COVID-19.